Page last updated: 2024-09-03

annamycin and Acute Lymphoid Leukemia

annamycin has been researched along with Acute Lymphoid Leukemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreeff, M; Ford, LA; Heffner, TL; Kantarjian, HM; O'Brien, S; Parekh, S; Shepard, R; Thomas, DA; Wang, ES; Wetzler, M1
Alvarado, Y; Apostolidou, E; Giles, FJ; Swords, R1

Reviews

1 review(s) available for annamycin and Acute Lymphoid Leukemia

ArticleYear
Emerging therapeutic options for Philadelphia-positive acute lymphocytic leukemia.
    Expert opinion on emerging drugs, 2007, Volume: 12, Issue:1

    Topics: Animals; Antineoplastic Agents; Doxorubicin; Fusion Proteins, bcr-abl; Glutamates; Guanine; Humans; Pemetrexed; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sulfonamides; Vincristine

2007

Trials

2 trial(s) available for annamycin and Acute Lymphoid Leukemia

ArticleYear
Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia.
    Clinical lymphoma, myeloma & leukemia, 2013, Volume: 13, Issue:4

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Female; Humans; Liposomes; Male; Middle Aged; Nanoparticles; Neoplasm Grading; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Young Adult

2013
Aronex Pharmaceuticals reports on annamycin phase I trial.
    Expert review of anticancer therapy, 2001, Volume: 1, Issue:1

    Topics: Acute Disease; Antibiotics, Antineoplastic; Doxorubicin; Heart; Humans; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2001